Dysregulation of miRNA and its potential therapeutic application in schizophrenia

67Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

Abstract

Although it is generally believed that genetic and developmental factors play critical roles in pathogenesis of schizophrenia, however, the precise etiological mechanism of schizophrenia remains largely unknown. Over past decades, miRNAs have emerged as an essential post-transcriptional regulator in gene expression regulation. The importance of miRNA in brain development and neuroplasticity has been well-established. Abnormal expression and dysfunction of miRNAs are known to involve in the pathophysiology of many neuropsychiatric diseases including schizophrenia. In this review, we summarized the recent findings in the schizophrenia-associated dysregulation of miRNA and functional roles in the development and pathogenesis of schizophrenia. We also discussed the potential therapeutic implications of miRNA regulation in the illness.

Cite

CITATION STYLE

APA

Cao, T., & Zhen, X. C. (2018, July 1). Dysregulation of miRNA and its potential therapeutic application in schizophrenia. CNS Neuroscience and Therapeutics. Blackwell Publishing Ltd. https://doi.org/10.1111/cns.12840

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free